Aesthetic Medical International Holdings Group (AIH) Stock News

Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) announced it will release its annual report for the fiscal year of 2022 before the U.S. market opens on April 21, 2023. The company will host a conference call at 8:00 AM Eastern Time (8:00 PM Beijing Time) on the same day to discuss its financial performance. Participants must preregister online for the call, after which they will receive dial-in numbers and a unique PIN. AIH operates aesthetic medical service centers primarily in major cities across China, focusing on the Guangdong-Hong Kong-Macau Greater Bay and Yangtze River Delta areas, providing a broad range of aesthetic treatments.

Aesthetic Medical International Holdings Group Limited (AIH) has requested a hearing before the Nasdaq Hearings Panel to seek an extension for meeting the $10 million stockholders’ equity requirement for continued listing on Nasdaq. This request follows a notification from Nasdaq regarding potential delisting. AIH expects to regain compliance after securing an investment of RMB170 million from Hainan Oriental Jiechuang Partnership within two months, which is pending necessary government approvals. The company's efforts indicate a focus on improving its financial standing amidst challenges posed by COVID-related delays.

Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) reported its Q3 2022 financial results, revealing a 0.3% decrease in revenue to RMB167.0 million (USD23.5 million) compared to Q3 2021. The company faced challenges due to COVID-19 restrictions leading to temporary closures of treatment centers. However, gross profit increased 22.5% to RMB86.6 million (USD12.2 million), with a gross margin rise to 51.8%. Adjusted loss after tax narrowed to RMB3.7 million (USD0.5 million). A strategic focus on operational efficiency and marketing improvements was noted, despite a 13.5% drop in active customers.

Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH), a leading provider of aesthetic medical services in China, will release its unaudited financial results for Q3 2022 on November 29, 2022, before U.S. market opens. The company will hold a conference call at 7:00 AM ET to discuss its financial performance. Participants must preregister to obtain dial-in numbers and access PINs. AIH operates treatment centers across China and offers various aesthetic services leveraging over 20 years of experience.

Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) reported its unaudited financial results for H1 2022, revealing a 10.6% year-on-year revenue increase to RMB338.6 million (USD50.6 million) and a gross profit surge of 48.0% to RMB188.7 million (USD28.2 million). Despite pandemic-related disruptions, customer numbers rebounded, with a 138.8% recovery in June sales compared to March. The company narrowed its net loss to RMB3.7 million, a substantial improvement from RMB473.0 million in H1 2021. Strategic initiatives include enhancing customer retention and operational efficiency through a new CRM system and SOPs.

Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) announced it will release its unaudited financial results for the first half of 2022 on August 17, 2022, before U.S. market opens. A conference call will be held at 8:00 AM ET on the same day to discuss the results. Participants must preregister to receive dial-in numbers. AIH is a prominent provider of aesthetic medical services in China, focusing on major urban areas and offering a variety of treatments.

Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) has entered into several agreements involving share purchase, subscription, and cooperation effective July 20, 2022. Key actions include a Share Purchase Agreement with Wanda for 21,321,962 shares at RMB4.67 per share, and a Subscription Agreement with Jiechuang for 36,402,570 newly issued shares at the same price. These transactions require shareholder approval and are expected to close in Q4 2022, subject to customary conditions. The agreements will affect board composition and shareholder rights.

Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) has successfully closed a private placement offering, issuing 21,413,276 ordinary shares at RMB4.67 each, raising gross proceeds of RMB100 million. The net proceeds are earmarked for business expansion and working capital, as approved by investors. The shares sold in this offering remain unregistered under the Securities Act and cannot be sold in the U.S. without proper registration or exemption.

Aesthetic Medical International Holdings Group Limited (AIH) reported a robust financial performance for the first quarter of 2022, achieving total revenue of RMB160.7 million (USD25.4 million), marking an 18.9% increase from the previous year. The restructuring focus on non-surgical aesthetic treatments led to a significant improvement in gross profit, which rose by 90.2% to RMB89.0 million (USD14.0 million). Despite temporary operational disruptions due to COVID-19, the company showcased a strong customer rebound in June with a 108% recovery rate. Adjusted net profit stood at RMB4.3 million (USD0.7 million), a notable turnaround from losses in the same period last year.